Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
8.16
+0.07 (0.87%)
Apr 29, 2026, 3:00 PM CST
SHA:600789 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 8,529 | 9,449 | 8,582 | 6,361 | 6,418 | 6,593 | Upgrade
|
| Market Cap Growth | -14.73% | 10.09% | 34.92% | -0.89% | -2.66% | -20.06% | Upgrade
|
| Enterprise Value | 9,212 | 11,813 | 10,613 | 8,698 | 8,777 | 8,485 | Upgrade
|
| Last Close Price | 8.16 | 9.04 | 9.44 | 6.96 | 7.02 | 7.18 | Upgrade
|
| PE Ratio | 92.32 | 84.13 | 21.75 | 25.84 | 46.50 | 74.00 | Upgrade
|
| PS Ratio | 1.49 | 1.64 | 1.38 | 1.03 | 1.14 | 1.34 | Upgrade
|
| PB Ratio | 1.61 | 1.80 | 2.11 | 1.70 | 1.83 | 1.92 | Upgrade
|
| P/TBV Ratio | 1.94 | 2.18 | 2.72 | 2.20 | 2.33 | 2.43 | Upgrade
|
| P/FCF Ratio | 16.93 | 26.30 | 69.42 | 23.91 | 400.72 | - | Upgrade
|
| P/OCF Ratio | 10.21 | 13.53 | 21.31 | 10.53 | 14.44 | 37.15 | Upgrade
|
| EV/Sales Ratio | 1.61 | 2.05 | 1.70 | 1.42 | 1.56 | 1.72 | Upgrade
|
| EV/EBITDA Ratio | 12.36 | 16.32 | 14.83 | 13.44 | 16.19 | 18.82 | Upgrade
|
| EV/EBIT Ratio | 32.47 | 43.00 | 33.51 | 32.68 | 45.23 | 59.19 | Upgrade
|
| EV/FCF Ratio | 18.29 | 32.88 | 85.85 | 32.69 | 547.99 | - | Upgrade
|
| Debt / Equity Ratio | 0.50 | 0.58 | 0.70 | 0.77 | 0.81 | 0.77 | Upgrade
|
| Debt / EBITDA Ratio | 3.56 | 4.24 | 3.97 | 4.44 | 5.26 | 5.88 | Upgrade
|
| Debt / FCF Ratio | 5.26 | 8.54 | 22.97 | 10.81 | 178.17 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.10 | 0.14 | 0.51 | 0.56 | 0.62 | 0.60 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.72 | 1.00 | 2.89 | 3.21 | 3.99 | 4.59 | Upgrade
|
| Net Debt / FCF Ratio | 1.07 | 2.02 | 16.71 | 7.80 | 135.08 | -6.66 | Upgrade
|
| Asset Turnover | 0.60 | 0.60 | 0.70 | 0.70 | 0.68 | 0.65 | Upgrade
|
| Inventory Turnover | 3.40 | 3.29 | 3.33 | 3.25 | 3.29 | 3.64 | Upgrade
|
| Quick Ratio | 1.10 | 1.07 | 0.84 | 0.61 | 0.47 | 0.41 | Upgrade
|
| Current Ratio | 1.53 | 1.46 | 1.35 | 1.04 | 0.85 | 0.79 | Upgrade
|
| Return on Equity (ROE) | 1.82% | 2.40% | 10.47% | 7.08% | 4.13% | 2.65% | Upgrade
|
| Return on Assets (ROA) | 1.86% | 1.80% | 2.21% | 1.90% | 1.47% | 1.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.90% | 3.15% | 4.99% | 4.36% | 3.31% | 2.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.20% | 4.10% | 5.20% | 5.00% | 4.20% | 3.30% | Upgrade
|
| Earnings Yield | 1.02% | 1.19% | 4.60% | 3.87% | 2.15% | 1.35% | Upgrade
|
| FCF Yield | 5.91% | 3.80% | 1.44% | 4.18% | 0.25% | -4.72% | Upgrade
|
| Dividend Yield | 1.63% | - | 1.40% | 1.29% | 0.71% | 0.70% | Upgrade
|
| Payout Ratio | 187.31% | 148.08% | 59.17% | 58.38% | 101.14% | 186.75% | Upgrade
|
| Buyback Yield / Dilution | -8.73% | -4.35% | -2.01% | 4.45% | -3.27% | 2.25% | Upgrade
|
| Total Shareholder Return | -7.09% | -4.35% | -0.61% | 5.74% | -2.55% | 2.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.